Claims
- 1. A polynucleotide microarray comprising at least one polynucleotide set forth in Table 1, Table 2, Table 3 or Table 4, wherein expression of said polynucleotide is either increased or decreased in brain cells in response to stress compared to normal brain cells.
- 2. A method for screening a compound for effectiveness in altering expression of a target polynucleotide wherein said target polynucleotide comprises a polynucleotide selected from Table 1, Table 2, Table 3 or Table 4, wherein said polynucleotide expression is either increased or decreased in brain cells in response to stress compared to normal brain cells.
- 3. A method of treating depression in a mammal comprising administering a compound identified in the method of claim 2.
CROSS-REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of United States Provisional Application Ser. No. 60/238,374, filed on Oct. 6, 2000, and U.S. Provisional Application Ser. No. 60/295,782, filed on Jun. 4, 2001.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60238374 |
Oct 2000 |
US |
|
60295782 |
Jun 2001 |
US |